# AccuVein

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/accuvein

- Industry: Medical Devices & Equipment
- Headquarters: New York, US
- Website: www.accuvein.com
- Total disclosed funding: $23M
- Latest round: Series B (Oct 24, 2011)
- Investors on record: 2

## About

AccuVein Inc. provides advanced vein visualization solutions that enhance vascular access procedures, improving efficiency and effectiveness for healthcare professionals. Their innovative technology aids in accurate needle placement, thereby enhancing patient care.AccuVein Inc. was founded in 2006 in New York, US, focusing on vein visualization technology. The company has raised a total of USD 0.50 mn across 4 deals, with the most recent funding round being Venture Debt in October 2019, amounting to USD 2.00 mn. The CEO is Chris Hutchison, who has prior experience in the medical device sector.AccuVein, Inc. specializes in advanced vein visualization solutions designed to enhance the efficiency and effectiveness of vascular access procedures. Their core product, the AccuVein device, utilizes near-infrared (NIR) technology to illuminate veins, valves, and bifurcations that are typically not visible to the naked eye. This innovation aids healthcare professionals in making informed decisions regarding needle placement, thereby improving first-attempt success rates for peripheral intravenous (PIV) catheter insertions. The devices are employed primarily in acute care settings, non-acute care facilities, and aesthetic practices, effectively serving a diverse clientele that includes hospitals, outpatient clinics, and specialized treatment centers across North America, Europe, and Asia. The company's commitment to healthcare equity ensures that their solutions are accessible to a broad spectrum of end users, ultimately enhancing patient care and satisfaction.AccuVein generates revenue through direct sales of its flagship vein visualization devices and associated accessories to healthcare providers, including hospitals and outpatient clinics. The company's transactional structure consists of B2B sales, focusing on building long-term relationships with healthcare organizations that integrate AccuVein’s technology into their vascular access protocols. These transactions typically involve one-time purchases of the devices, as well as recurring sales of consumables or accessories necessary for the operation of the vein visualization systems. Pricing plans reflect the value of the technology in improving procedural efficiency and patient outcomes, aligning with industry standards for medical device pricing. The commitment to enhancing patient experience and operational performance positions AccuVein as a pivotal player in the medical sales sector, particularly within the vein visualization niche.AccuVein plans to launch new products designed to further improve vein visualization technology, with specific release dates yet to be announced. The company is looking to expand into new markets across North America, Europe, and Asia by 2024. The USD 2.00 mn raised in the most recent funding round will support these initiatives, helping to develop new products and enhance market penetration.

## Funding rounds

- Series B, Oct 24, 2011, $0.5M — MVM Partners, Bessemer Venture Partners
- Series B, Jul 27, 2011, $23M — MVM Partners, Bessemer Venture Partners

## Investors

- MVM Partners (https://capitalatlas.ai/funds/mvm-partners) — Series B
- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Series B